Sentiment analysis of social media posts on pharmacotherapy: A scoping review

Abstract

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Spontaneously generated online patient experience data - how and why is it being used in health research: an umbrella scoping review

“…A Systematic Review Identify and highlight research issues and methods used in studying Complementary and Alternative Medicine (CAM) information needs, access, and exchange over the Internet. CAM Any SM Systematic 120 Sharma 2020 [ 62 ] Sentiment analysis of social media posts on pharmacotherapy: A Scoping Review The aim of this scoping review was to describe the available evidence as it pertains to SA of Social Media specifically about pharmacotherapy. Themes will be generated about the published uses of SA and the real-world implications of the knowledge generated.…”

“…Six (10%) of the reviews looked entirely at Twitter based studies [ 15 , 37 , 46 , 49 , 63 , 72 ]. A further eighteen (31%) reviews included a wider range of sites but reported that Twitter was the most frequently used source [ 20 , 24 , 25 , 28 , 29 , 33 , 39 – 41 , 45 , 48 , 54 , 59 , 60 , 62 , 67 , 74 ]. Both general health sites and disease specific communities covering a wide range of conditions were also widely accessed [ 20 , 23 , 24 , 26 , 31 , 33 , 35 , 42 , 45 , 51 , 58 , 74 ].…”

“…Lots more work required. Sharma 2020 [ 62 ] Can sentiment analysis be conducted on social media platforms to understand public sentiment held towards pharmacotherapy? Any Author, Year, Journal, data source, conditions, pharmacotherapy, SA method used, potential clinical use.…”

“…In terms of the specific health topic of interest, 22/58 papers included any health condition [ 7 , 15 , 16 , 21 , 30 , 32 , 34 , 36 , 37 , 39 , 44 , 45 , 47 , 52 , 54 , 55 , 62 , 65 , 69 , 72 – 74 ]. Twelve focused on mental health conditions [ 20 , 23 , 24 , 28 , 42 , 48 , 50 , 53 , 58 , 64 , 66 , 71 ], 9 on adverse drug reactions (ADRs) [ 31 , 43 , 46 , 51 , 57 , 67 , 68 , 70 , 75 ], 4 on infectious diseases [ 25 , 29 , 40 , 41 ], two each on chronic disease [ 26 , 56 ], substance misuse [ 49 , 60 ], public health [ 27 , 59 ], breast cancer [ 33 , 38 ] and with one each for symptom identification [ 35 ], use of complementary and alternative medicine (CAM) therapies [ 61 ] and the reasons for existing use by health researchers [ 63 ].…”

“…Other use areas included assessing the opportunities, benefits, challenges and limitations that using SGOPE data might offer healthcare providers and researchers [ 23 , 25 , 36 , 37 , 42 , 45 , 52 , 57 , 62 , 64 , 71 , 73 ]. Benefits identified included providing a new channel for hearing patient perspectives of their health experiences [ 23 , 33 , 42 ], faster data collection and reduced costs [ 25 , 33 ], and improved support for self-management of health conditions [ 26 ].…”